Action BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues BioForce Nanosciences Holdings, Inc.

Actions

BFNH

US09064C2061

Marché Fermé - OTC Markets
Autres places de cotation
 20:49:50 07/06/2024 		Varia. 5j. Varia. 1 janv.
0,99 USD +1,02 % Graphique intraday de BioForce Nanosciences Holdings, Inc. -18,18 % -50,75 %
03/05 BioForce Nanosciences Holdings, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
01/04 BioForce Nanosciences Holdings, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
BIOFORCE NANOSCIENCES HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
BIOFORCE NANOSCIENCES HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
BioForce Nanosciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
BioForce Nanosciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt
BIOFORCE NANOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
BioForce Nanosciences Holdings, Inc. Announces CEO Changes
BioForce Nanosciences Holdings, Inc. Appoints Sasha Shapiro as President, Effective November 30, 2021
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BFNH
  4. Actualités BioForce Nanosciences Holdings, Inc.
  5. Autres langues